Skip to content

Impact of Maternal Glycolipid Metabolism in Early Pregnancy on Congenital Heart Disease in Offspring and Its Related Mechanisms

Impact of Maternal Glycolipid Metabolism in Early Pregnancy on Congenital Heart Disease in Offspring and Its Related Mechanisms

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800016635
Enrollment
Unknown
Registered
2018-06-14
Start date
2018-06-15
Completion date
Unknown
Last updated
2018-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

congenital heart diseases

Interventions

Non-exposed group:not applicable

Sponsors

Xiangya School of Public Health, Central South University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Pregnant women in early pregnancy; 2. Pregnant women who agreed to participate in the study; 3. pregnant women who completed the whole research process, and the outcome index diagnosis is clear.

Exclusion criteria

Exclusion criteria: 1. Pregnant women who did not agree to participate in the study; 2. Pregnant women with severe disorders such as mental disorders; 3. Lost visitor.

Design outcomes

Primary

MeasureTime frame
Glucose and Lipid Metabolism Indexes of mothers in early pregnancy;Fetal Cardiac specific transcription Factor Gene Polymorphism;Diagnosis of congenital heart disease;

Countries

China

Contacts

Public ContactJiabi Qin

Xiangya School of Public Health, Central South University

qinjiabi123@163.com+86 15974269544

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 19, 2026